VolitionRX Ltd (AMEX:VNRX)’s traded shares stood at 0.24 million during the last session, with the company’s beta value hitting 1.27. At the close of trading, the stock’s price was $0.74, to imply a decrease of -1.53% or -$0.01 in intraday trading. The VNRX share’s 52-week high remains $0.94, putting it -27.03% down since that peak but still an impressive 45.95% since price per share fell to its 52-week low of $0.40. The company has a valuation of $76.24M, with an average of 0.36 million shares in intraday trading volume over the past 10 days and average of 292.06K shares over the past 3 months.

VolitionRX Ltd (AMEX:VNRX) trade information

After registering a -1.53% downside in the last session, VolitionRX Ltd (VNRX) has traded red over the past five days. The 5-day price performance for the stock is -14.75%, and 37.32% over 30 days. With these gigs, the year-to-date price performance is 19.55%. Short interest in VolitionRX Ltd (AMEX:VNRX) saw shorts transact 0.18 million shares and set a 0.61 days time to cover.

VNRX Dividends

VolitionRX Ltd has its next earnings report out on 2025-May-15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

VolitionRX Ltd (AMEX:VNRX)’s Major holders

VolitionRX Ltd insiders hold 18.46% of total outstanding shares, with institutional holders owning 20.39% of the shares at 25.01% float percentage. In total, 20.39% institutions holds shares in the company, led by LAGODA INVESTMENT MANAGEMENT, L.P. As of 2024-06-30, the company held over 5.44 million shares (or 6.578% of shares), all amounting to roughly $3.29 million.

The next major institution holding the largest number of shares is VANGUARD GROUP INC with 0.64 million shares, or about 0.7701% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.39 million.